Obesity and childhood survivors of acute lymphoblastic leukemia: Do genetics play a role?

Cheryl Mele

Drexel University Clemson University Doctoral Student in Healthcare of Genetics Program.

DOI: 10.4236/ojgen.2012.21010                

Abstract

Childhood survivors of acute lymphoblastic leukemia (ALL) are increased risk of several chronic complications, such as second cancers, pulmonary, metabolic complications and cardiovascular disease. Obesity and metabolic syndrome is one of the most common treatment related complication in children surviving cancer, which concurs with our nations childhood epidemic [1-3] Recent research has identified the role of genetics in the development of obesity and metabolic syndrome in childhood survivors of ALL. Growth hormone deficiency, Leptin regulation, fat mass obesity (FTO) gene and the insulin resistant ENPP1 variants disorders has been associated adverse effects of chemotherapeutic treatment and the cause of clinical manifestations of metabolic syndrome [4-8]. The illumination of the role of genetic variants can shed insights into obesity within high risk population, as well as, a target to prevent disease.

Keywords

Genetic Polymorphisms; Obesity; Metabolic Syndrome; Acute Lymphoblastic Leukemia

Conflicts of Interest

The authors declare no conflicts of interest.

References

[1]	Karman, S. et al. (2010) Late effects of childhood ALL treatment on body mass index and serum leptin levels. Journal of Pediatric Endocrinology Metabolism, 23, 669- 674. doi:10.1515/JPEM.2010.23.7.669
[2]	Pakakasama, S. et al. (2010) Late effects of childhood acute lymphoblastic leukemia: a study from the Thai pediatric oncology group. International Journal of Hematology, 91, 785-854. doi:10.1007/s12185-010-0594-9
[3]	Tabon, M. and Leverger G. (2009) Outcome of children cured of Acute lymphoblastic Leukemia. Bulletin de l’Aca-démie Nationale de Médecine, 193, 1519-1528.
[4]	Bottcher, Y. et al. (2006) ENPP1 Variants and haplotypes predispose to early onset obesity and impaired glucose and insulin metabolism in german obese children. Journal of Clinical Endocrinology and Metabolism, 91, 4948- 4952. doi:10.1210/jc.2006-0540
[5]	Kourti, M. et al. (2005) Metabolic syndrome in children and adolescents with acute lymphoblastic leukemia after completion of chemotherapy. Clinical and Laboratory Observations, 27, 499-501.
[6]	Ross, J. (2006) Genetic susceptibility and body mass in childhood cancer survivors. Pediatric Blood Cancer, 48, 731-735. doi:10.1002/pbc.21112
[7]	Sivero-Miachon, A. et al. (2008) Detection of metabolic syndrome features among childhood cancer survivors: A target to prevent disease. Vascular Health and Risk Management, 4, 825-836.
[8]	Siviero-Miachon, A., Spinla-Castro, A. and Guerra-Junior G. (2009) Adiposity in childhood cancer survivors: Insights into obesity physiopathology. Arquivos Brasileiros de Endocrinologia e Metabologia, 53, 190-199. doi:10.1590/S0004-27302009000200011
[9]	Pui, C.H. et al. (2003) Results of therapy for acute lymphoblastic leukemia in black and white children. JAMA 290, 2001-2007. doi:10.1001/jama.290.15.2001
[10]	Oeffinger, K.C. et al. (2003) Obesity in adult survivors of childhood acute lymphoblastic leukemia: A report from the childhood cancer survivor study. Journal of Clinical Oncology, 21, 1359-1365. doi:10.1200/JCO.2003.06.131
[11]	Rogers, P.C. et al. (2005) Obesity in pediatric oncology. Pediatric Blood Cancer, 45, 881-891. doi:10.1002/pbc.20451
[12]	Nathan, P.C. et al. (2006) The prevalence of overweight and obesity in pediatrics survivors of cancer. Journal of Pediatric, 149, 518-525. doi:10.1016/j.jpeds.2006.06.039
[13]	Garmey, E. et al. (2008) Longitudinal changes in obesity and body mass index amon adult survivors of childhood acute lymphoblastic leukemia: A report From the childhood cancer survivor study. Journal of Clinical Oncology, 26, 4639-4645. doi:10.1200/JCO.2008.16.3527
[14]	Razzouk, B. et al. (2007) Obesity in childhood survivors of childhood acute lymphoblastic leukemia and lymphoma. Journal of Clinical Oncology, 5, 1183-1189. doi:10.1200/JCO.2006.07.8709
[15]	Armenian, S. and Bhatia, S. (2009) Chronic health conditions in childhood cancer survivors: Is it ALL treatment related or do genetics play a role. Journal of General Internal Medicine, 24, 395-400. doi:10.1007/s11606-009-0995-8
[16]	Janiszewski, P.M., et al. (2007) Abdominal obesity, liver fat, and muscle composition in childhood survivors of acute lymphoblastic leukemia. Journal of Clinical Endocrinology Metabolism, 92, 3816-3821. doi:10.1210/jc.2006-2178
[17]	Hino, M., Nakao, T., Yamane, T. (2000) Leptin receptor and leukemia. Leukemia Lymphoma, 35, 457-461. doi:10.3109/10428190009148392
[18]	Skoczen, S., Surmiak, M. and Wojciech, S. (2010) Survivors of acute lymphoblastic leukemia and body mass changes. Expert Opinion Drug Safety, 9, 65-76. doi:10.1517/14740330903410213
[19]	Ross, J. and Oeffinger, K.C. (2004) Genetic variation in the leptin receptor gene and obesity in survivors of childhood acute lymphoblastic leukemia: A report from the childhood cancer survivor study. Journal of Clinical Oncology, 22, 3558-3562. doi:10.1200/JCO.2004.11.152
[20]	Van Waas, M. and Neggers, S.J.C.M.M. (2010) Components of the metabolic syndrome in 500 adult long-term survivors of childhood cancer. Annals of Oncology, 21, 1121-1126. doi:10.1093/annonc/mdp414
[21]	Fawcett, K. and Barroso I. (2010) The Genetics of obesity: The FTO gene leads the way. Trends Genetics, 26, 266- 274. doi:10.1016/j.tig.2010.02.006
[22]	Rendo, T. et al. (2009) Effects of the FTO gene on lifestyle interventions in children. Obesity Facts, 2, 393-399. doi:10.1159/000262296
[23]	Wang, T. et al. (2010 )The association between common genetic variation in the FTO gene an metabolic syndrome in Han Chinese. Chinese Medical Journal, 123, 1852-1858.
[24]	Surapolchai, S. et al. (2010) Impaired glucose tolerance and insulin resistance in survivors of childhood acute lymphoblastic leukemia: Prevalence and risk factors. Jour- nal of Pediatric Hematology Oncology, 32, 383-389.
[25]	Helgason, A. et al., Refining the impact of TCF7L2 gene variants on type 2 diabetes and adaptive evolution. Nature Genetics, 39, 218-225.
[26]	Plengvidhya, N. et al. (2007) PAX4 mutations in thais with maturity onset diabetes of the young. The Journal of Clinical Endocrinology & Metabolism, 92, 2821-2826. doi:10.1210/jc.2006-1927
[27]	Yun, J.P. et al. (2010) Dietinduced obesity accelerates acute lymphoblastic leukemia progression in two murine models. Cancer Prevention Research, 3, 1259-1264. doi:10.1158/1940-6207.CAPR-10-0087
[28]	Collins, L. et al. (2009) Growth in children with acute lymphoblastic leukemia during treatment. Journal of Pediatric Hematology Oncology, 32, 304-307. doi:10.1097/MPH.0b013e3181ece2bb
[29]	Withcombe, J. et al., (2009) Weight patterns in children with higher risk of ALL: A report from the Children’s Oncology Group (CCG) for CCG 1961. Pediatric Blood Cancer, 53, 1249-1254.
[30]	Jansen, H. et al. (2009) Acute lymphoblastic leukemia and obesity: Increased energy intake or decreased physical activity? Support Cancer Care, 17, 103-106. doi:10.1007/s00520-008-0531-0
[31]	Reilly, J. (2009) Obesity during and after treatment for childhood cancer. Endocrine Development, 15, 40-58. doi:10.1159/000207609
[32]	Robien, K. et al. (2008) Poor adherence to dietary guidelines among adult survivors of childhood acute lymphoblastic leukemia. Journal of Pediatric Hematology Oncology, 11, 815-822. doi:10.1097/MPH.0b013e31817e4ad9